RVP

Drug Catalog - Product Detail

TRIAMCINOLONE ACETONIDE OINTMENT USP 0.05%

NDC Mfr Size Str Form
74157-0901-90 INA PHARMACEUTICS 430 0.05% NA
Product Image
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. The steroids in this class include triamcinolone acetonide. Triamcinolone acetonide is designated chemically as 9-Fluoro-11b, 16a, 17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone. Graphic Formula: Each gram of 0.05% Triamcinolone Acetonide Ointment USP provides 0.5 mg Triamcinolone Acetonide USP in a water-in-oil emulsion composed of ceresin wax, lanolin alcohols, light mineral oil, liquid paraffin, purified water and white petrolatum. image description
How Supplied
HOW SUPPLIED Triamcinolone Acetonide Ointment USP, 0.05% is supplied in jars containing 430 g of ointment (NDC 74157-901-90).
Indications & Usage
INDICATIONS AND USAGE Triamcinolone Acetonide Ointment USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage and Administration
DOSAGE AND ADMINISTRATION Apply a thin film of Triamcinolone Acetonide Ointment 0.05% to the affected area two to four times daily. Occlusive Dressing Technique Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions. Apply a thin film of ointment to the lesion, cover with a pliable nonporous film, and seal the edges. If needed, additional moisture may be provided by covering the lesion with a dampened clean cotton cloth before the nonporous film is applied or by briefly wetting the affected area with water immediately prior to applying the medication. The frequency of changing dressings is best determined on an individual basis. It may be convenient to apply triamcinolone acetonide ointment under an occlusive dressing in the evening and to remove the dressing in the morning (i.e., 12-hour occlusion). When utilizing the 12-hour occlusion regimen, additional ointment should be applied, without occlusion, during the day. Reapplication is essential at each dressing change. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.